HIV-1 drug resistance and resistance testing

DS Clutter, MR Jordan, S Bertagnolio… - Infection, Genetics and …, 2016 - Elsevier
The global scale-up of antiretroviral (ARV) therapy (ART) has led to dramatic reductions in
HIV-1 mortality and incidence. However, HIV drug resistance (HIVDR) poses a potential …

HIV-1 antiretroviral resistance: scientific principles and clinical applications

MW Tang, RW Shafer - Drugs, 2012 - Springer
The efficacy of an antiretroviral (ARV) treatment regimen depends on the activity of the
regimen's individual ARV drugs and the number of HIV-1 mutations required for the …

Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society–USA Panel

HF Günthard, V Calvez, R Paredes… - Clinical Infectious …, 2019 - academic.oup.com
Background Contemporary antiretroviral therapies (ART) and management strategies have
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …

COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification

D Struck, G Lawyer, AM Ternes, JC Schmit… - Nucleic acids …, 2014 - academic.oup.com
Viral sequence classification has wide applications in clinical, epidemiological, structural
and functional categorization studies. Most existing approaches rely on an initial alignment …

Global trends in molecular epidemiology of HIV-1 during 2000–2007

J Hemelaar, E Gouws, PD Ghys, S Osmanov - Aids, 2011 - journals.lww.com
Objective: To estimate the global and regional distribution of HIV-1 subtypes and
recombinants between 2000 and 2007. Design: Country-specific HIV-1 molecular …

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

JZ Li, R Paredes, HJ Ribaudo, ES Svarovskaia… - Jama, 2011 - jamanetwork.com
Context Presence of low-frequency, or minority, human immunodeficiency virus type 1 (HIV-
1) drug resistance mutations may adversely affect response to antiretroviral treatment (ART) …

HIV‐1 genetic variability and clinical implications

MM Santoro, CF Perno - International Scholarly Research …, 2013 - Wiley Online Library
Despite advances in antiretroviral therapy that have revolutionized HIV disease
management, effective control of the HIV infection pandemic remains elusive. Beyond the …

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study

F Kiweewa, A Esber, E Musingye, D Reed, TA Crowell… - PloS one, 2019 - journals.plos.org
Introduction The 2016 WHO consolidated guidelines on the use of antiretroviral drugs
defines HIV virologic failure for low and middle income countries (LMIC) as plasma HIV …

[PDF][PDF] British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011.

D Asboe, C Aitken, M Boffito, C Booth, P Cane… - HIV medicine, 2012 - bhiva.org
In the mid-1990s, the clinical care of patients with HIV infection changed fundamentally as a
result of the development and introduction of effective antiretroviral therapy (ART). This led …

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

AB Abecasis, AMJ Wensing, D Paraskevis… - Retrovirology, 2013 - Springer
Background Understanding HIV-1 subtype distribution and epidemiology can assist
preventive measures and clinical decisions. Sequence variation may affect antiviral drug …